116 related articles for article (PubMed ID: 19574641)
21. A recombinant anti-erbB2, scFv-Fc-IL-2 fusion protein retains antigen specificity and cytokine function.
Shi M; Xie Z; Feng J; Sun Y; Yu M; Shen B; Guo N
Biotechnol Lett; 2003 May; 25(10):815-9. PubMed ID: 12882013
[TBL] [Abstract][Full Text] [Related]
22. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
23. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
24. Crystallization and preliminary crystallographic studies on the large extracellular domain of human CD81, a tetraspanin receptor for hepatitis C virus.
Kitadokoro K; Galli G; Petracca R; Falugi F; Grandi G; Bolognesi M
Acta Crystallogr D Biol Crystallogr; 2001 Jan; 57(Pt 1):156-8. PubMed ID: 11134943
[TBL] [Abstract][Full Text] [Related]
25. Biochemical implications from the variable gene sequences of an anti-cytochrome c antibody and crystallographic characterization of its antigen-binding fragment in free and antigen-complexed forms.
Mylvaganam SE; Paterson Y; Kaiser K; Bowdish K; Getzoff ED
J Mol Biol; 1991 Sep; 221(2):455-62. PubMed ID: 1656053
[TBL] [Abstract][Full Text] [Related]
26. Crystallization and preliminary diffraction studies of prostaglandin E2-specific monoclonal antibody Fab fragment in the ligand complex.
Kurahashi Y; Sugahara M; Ago H; Aoyama S; Takahashi N; Takio K; Katsukawa M; Yamamoto S; Miyano M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):1027-30. PubMed ID: 18997333
[TBL] [Abstract][Full Text] [Related]
27. Crystallization and preliminary crystallographic analysis of the central domain of Drosophila Dribble, a protein that is essential for ribosome biogenesis.
Cheng TC; Chen YW; Wong KB; Ngai SM; Chan HY
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May; 66(Pt 5):546-8. PubMed ID: 20445256
[TBL] [Abstract][Full Text] [Related]
28. Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity.
Chang L; Zhou C; Xu M; Liu J
J Comput Aided Mol Des; 2010 Jan; 24(1):37-47. PubMed ID: 20012671
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.
Schier R; Marks JD; Wolf EJ; Apell G; Wong C; McCartney JE; Bookman MA; Huston JS; Houston LL; Weiner LM
Immunotechnology; 1995 May; 1(1):73-81. PubMed ID: 9373335
[TBL] [Abstract][Full Text] [Related]
30. [Expression and Characterization of Single-chain Fv-Fc Fusion Protein against Human P185(erbB2)].
Xie ZG; Guo N; Shi M; Feng JN; Yu M; Sun YX; Shen BF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):371-4. PubMed ID: 12673393
[TBL] [Abstract][Full Text] [Related]
31. Crystallization and preliminary X-ray crystallographic studies on a Fab fragment of the mouse anti-human Fas monoclonal antibody HFE7A.
Ito S; Takayama T; Hanzawa H; Ichikawa K; Ohsumi J; Serizawa N; Haruyama H; Hata T
Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1700-2. PubMed ID: 11679750
[TBL] [Abstract][Full Text] [Related]
32. De novo design of ErbB2 epitope targeting fusion protein stabilized by coiled coil structure.
Wang J; Feng J; Shi M; Qian L; Chen L; Yu M; Xu R; Shen B; Guo N
Mol Immunol; 2008 Jan; 45(1):106-16. PubMed ID: 17572496
[TBL] [Abstract][Full Text] [Related]
33. Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin.
De Lorenzo C; Troise F; Cafaro V; D'Alessio G
Br J Cancer; 2007 Nov; 97(10):1354-60. PubMed ID: 17923870
[TBL] [Abstract][Full Text] [Related]
34. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors.
Garrett TP; McKern NM; Lou M; Elleman TC; Adams TE; Lovrecz GO; Kofler M; Jorissen RN; Nice EC; Burgess AW; Ward CW
Mol Cell; 2003 Feb; 11(2):495-505. PubMed ID: 12620236
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
[TBL] [Abstract][Full Text] [Related]
36. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene.
Gerstmayer B; Altenschmidt U; Hoffmann M; Wels W
J Immunol; 1997 May; 158(10):4584-90. PubMed ID: 9144470
[TBL] [Abstract][Full Text] [Related]
37. Crystallization and preliminary X-ray crystallographic study of the human MST2 SARAH domain.
Song J; Hong H; Choi S; Lee YH; Yamashita E; Bae SC; Park IY; Lee SJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Nov; 67(Pt 11):1403-5. PubMed ID: 22102242
[TBL] [Abstract][Full Text] [Related]
38. Overexpression, purification, crystallization and preliminary X-ray crystallographic analysis of the periplasmic domain of outer membrane protein A from Acinetobacter baumannii.
Park JS; Lee WC; Choi S; Yeo KJ; Song JH; Han YH; Lee JC; Kim SI; Jeon YH; Cheong C; Kim HY
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Dec; 67(Pt 12):1531-3. PubMed ID: 22139158
[TBL] [Abstract][Full Text] [Related]
39. Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.
Miyazawa M; Kitadokoro K; Kamitani S; Shime H; Horiguchi Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):906-8. PubMed ID: 16946476
[TBL] [Abstract][Full Text] [Related]
40. 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.
Essen LO; Harrenga A; Ostermeier C; Michel H
Acta Crystallogr D Biol Crystallogr; 2003 Apr; 59(Pt 4):677-87. PubMed ID: 12657787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
